Figure 2.
Percentage of patients in each treatment group achieving improvement according to the American College of Rheumatology response criteria for an improvement of at least 20% (ACR20) (A), 50% (ACR50) (B), and 70% (ACR70) (C) over the 12‐week treatment course (full analysis set, nonresponder imputation). SC = subcutaneous; EOW = every other week; EW = every week.